Criteria for the identification of non-redox inhibitors of 5-lipoxygenase
- 1 February 1993
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 45 (4) , 978-981
- https://doi.org/10.1016/0006-2952(93)90185-y
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Development of L-689,065 - the prototype of a new class of potent 5-lipoxygenase inhibitorsBioorganic & Medicinal Chemistry Letters, 1992
- Bronchodilator properties of an inhaled leukotriene D4 antagonist (verlukast—MK-0679) in asthmatic patientsPulmonary Pharmacology, 1992
- (Methoxyalkyl)thiazoles: a new series of potent, selective, and orally active 5-lipoxygenase inhibitors displaying high enantioselectivityJournal of Medicinal Chemistry, 1991
- Inhibition of human leukocyte 5-lipoxygenase by a 4-hydroxybenzofuran, L-656,224: Evidence for enzyme reduction and inhibitor degradationBiochemical Pharmacology, 1991
- Pseudoperoxidase activity of 5-lipoxygenase stimulated by potent benzofuranol and N-hydroxyurea inhibitors of the lipoxygenase reactionBiochemical Journal, 1991
- Selective chiral inhibitors of 5‐lipoxygenase with anti‐inflammatory activityBritish Journal of Pharmacology, 1990
- Selective 5-lipoxygenase inhibition in ulcerative colitisThe Lancet, 1990
- Sensitivity of immunoaffinity-purified porcine 5-lipoxygenase to inhibitors and activating lipid hydroperoxidesBiochemical Pharmacology, 1989
- Reductive inactivation of soybean lipoxygenase 1 by catechols: a possible mechanism for regulation of lipoxygenase activityBiochemistry, 1987
- Inhibition of soybean lipoxygenase 1 by N-alkylhydroxylaminesBiochemistry, 1985